✦ LIBER ✦

Prognostic significance of neuroendocrine differentiation in clinically localized prostatic carcinoma

✍ Scribed by Abrahamsson, Per-Anders; Cockett, Abraham T.K.; di Sant'Agnese, P. Anthony

Publisher: John Wiley and Sons
Year: 1998
Tongue: English
Weight: 130 KB
Volume: 36
Category: Article
ISSN: 0270-4137
DOI: 10.1002/(sici)1097-0045(1998)8+<37::aid-pros7>3.0.co;2-d

No coin nor oath required. For personal study only.

✦ Synopsis

Several recent studies have focused attention on neuroendocrine differentiation (NED) in prostatic carcinoma (PC). Clinical studies have shown PC with NED to behave aggressively and to be associated with poor prognosis. To evaluate NED as an independent prognostic factor, we conducted a retrospective study of 87 patients with clinically localized PC who underwent radical prostatectomy. The presence of neuroendocrine tumor cells was confirmed by positive immunostaining for serotonin, chromogranin A, and neuronspecific enolase. The correlation between NED and disease progression was assessed. Progression of cancer was demonstrated in 35 (40%) of the patients. The presence of NED was confirmed in 60 (69%) of cases, and of these patients 26 (43%) manifested evidence of disease progression. Disease progression was also manifest in nine (33%) of the 27 patients without evidence of NED. Thus, in the setting of clinically localized carcinoma of the prostate, NED does not appear to be a statistically significant independent prognostic factor.

📜 SIMILAR VOLUMES

Prognostic significance of p16 and CDK4

Prognostic significance of p16 and CDK4 proteins in localized prostate carcinoma

✍ Ole J. Halvorsen; Jens Høstmark; Svein Haukaas; Per Å. Høisæter; Lars A. Akslen 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 1 views

## Background: In prostate carcinoma, a very low frequency of point mutations of the tumor suppressor gene cdkn2/mts1 (p16(ink4) ) has been reported, but deletions of 9p21 and inactivation by promoter methylation are observed more frequently. in the current study the authors evaluated the expressio

An enhanced prognostic system for clinic

An enhanced prognostic system for clinically localized carcinoma of the prostate

✍ Thomas M. Pisansky; Michael J. Kahn; David G. Bostwick 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB 👁 1 views

## Background: This investigation was conducted to develop an enhanced prognostic system based on readily available and independently predictive tumor-related factors for patients with clinically localized prostate carcinoma. ## Methods: The outcome of 500 patients treated solely with irradiation

Evaluation and clinical value of neuroen

Evaluation and clinical value of neuroendocrine differentiation in human prostatic tumors

✍ Cussenot, Olivier; Villette, Jean-Marie; Cochand-Priollet, Beatrix; Berthon, Phi 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 363 KB 👁 1 views

## BACKGROUND. Prostate cancer, like other solid tumors, is a rather heterogeneous entity. More than 50% of all malignant prostatic tumors contain neuroendocrine-like cells, which cannot be attributed to small cell prostatic carcinoma or carcinoid-like tumors, which represent only 1-2% of all prost

Neuroendocrine differentiation in carcin

Neuroendocrine differentiation in carcinomas of the prostate: Do neuroendocrine serum markers reflect immunohistochemical findings?

✍ Angelsen, Anders; Syversen, Unni; Haugen, Olav A.; Stridsberg, Mats; Mjølnerød, 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 307 KB

The aim of the present study was to examine the correlation between the immunohistochemical findings and the serum markers for neuroendocrine (NE) cells in patients with carcinoma of the prostate. Preoperative serum values of chromogranin A (CgA), chromogranin B (CgB), pancreastatin (Pst), neuron-sp

Recursive partitioning for prognostic gr

Recursive partitioning for prognostic grouping of patients with clinically localized prostate carcinoma

✍ Mousumi Banerjee; Debjit Biswas; Wael Sakr; David P. Wood Jr. 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB 👁 1 views

Prognostic factors for clinically locali

Prognostic factors for clinically localized prostate carcinoma : Analysis of 938 patients irradiated in the prostate specific antigen era

✍ Gunar K. Zagars; Alan Pollack; Andrew C. von Eschenbach 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 212 KB 👁 1 views

The Uniirradiated in the PSA era. versity of Texas, M. D. Anderson Cancer Center, ## METHODS. The authors analyzed the outcome for a group of 938 men with T1-T4,